Standard Biotools Inc (LAB) — Cash Flow-to-Debt Ratio
Standard Biotools Inc (LAB) has a Cash Flow-to-Debt Ratio of -0.60x as of March 2026, meaning its operating cash flow of $-46.60 Million could theoretically repay -1% of its total liabilities ($77.99 Million) in one year. Explore Standard Biotools Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Standard Biotools Inc Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Standard Biotools Inc across 20 annual periods. Also explore Standard Biotools Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Standard Biotools Inc (2006–2025)
Year-by-year debt coverage analysis for Standard Biotools Inc. For market capitalisation and broader financial context, see how much is Standard Biotools Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | $-74.35 Million | $143.46 Million | ▲ +49.2% |
| 2024 | -1.02x | $-143.45 Million | $140.62 Million | ▼ -1010.3% |
| 2023 | -0.09x | $-43.29 Million | $471.12 Million | ▲ +51.5% |
| 2022 | -0.19x | $-89.37 Million | $471.78 Million | ▲ +22.3% |
| 2021 | -0.24x | $-44.06 Million | $180.62 Million | ▼ -193.8% |
| 2020 | -0.08x | $-15.42 Million | $185.71 Million | ▲ +73.8% |
| 2019 | -0.32x | $-35.21 Million | $111.20 Million | ▼ -190.9% |
| 2018 | -0.11x | $-25.20 Million | $231.53 Million | ▼ -15.8% |
| 2017 | -0.09x | $-24.10 Million | $256.42 Million | ▲ +39.1% |
| 2016 | -0.15x | $-39.10 Million | $253.16 Million | ▼ -14.0% |
| 2015 | -0.14x | $-34.70 Million | $256.16 Million | ▼ -54.0% |
| 2014 | -0.09x | $-22.62 Million | $257.14 Million | ▼ -9.5% |
| 2013 | -0.08x | $-1.59 Million | $19.80 Million | ▲ +94.0% |
| 2012 | -1.34x | $-17.48 Million | $13.07 Million | ▼ -70.9% |
| 2011 | -0.78x | $-17.54 Million | $22.43 Million | ▼ -1354.2% |
| 2010 | -0.05x | $-11.51 Million | $213.97 Million | ▲ +43.3% |
| 2009 | -0.09x | $-19.51 Million | $205.77 Million | ▲ +37.0% |
| 2008 | -0.15x | $-28.72 Million | $190.69 Million | ▼ -28.1% |
| 2007 | -0.12x | $-21.76 Million | $185.11 Million | ▲ +24.8% |
| 2006 | -0.16x | $-22.31 Million | $142.66 Million | — |